Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

Antonio, Tursi,; Giovanni, Brandimarte,; Alfredo, Papa,; Andrea, Giglio,; Walter, Elisei,; Gian Marco, Giorgetti,; Giacomo, Forti,; Sergio, Morini,; Cesare, Hassan,; Maria Antonietta, Pistoia,; Maria Ester, Modeo,; Stefano, Rodino',; Teresa, D'Amico,; Ladislava, Sebkova,; Natale, Sacca',; Giulio, Emilio, Di; Francesco, Luzza,; Maria, Imeneo,; Tiziana, Larussa,; Rosa, Salvatore, Di; Vito, Annese,; Silvio, Danese,; Antonio, Gasbarrini,

doi:10.1038/ajg.2010.218

Public

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

Published in The American journal of gastroenterology • Oct 1, 2010

Authors:

Tursi, Antonio

Brandimarte, Giovanni

Papa, Alfredo

Abstract

OBJECTIVES: VSL#3 is a high-potency probiotic mixture that has been used successfully in the treatment of pouchitis. The primary end point of the study was to assess the effects of supplementation with VSL#3 in patients affected by relapsing ulcerative colitis (UC) who are already under treatment wi...

Subject

Adult

Azathioprine

Bifidobacterium

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!